[Criteria and recommendations for the treatment of HCV mono-infected patients]

2012 Ministerio de Sanidad, Servicios Sociales e Iguald

Treatment of HCV mono-infected naive patients, non-responders or partial responders by Boceprevir or Telaprevir is recommended by the Spanish Ministry of Health depending on the stage of fibrosis assessed either by liver biopsy or by liver stiffness assessment by FibroScan. A liver stiffness < 7.6 kPa is considered equivalent to F0F1 METAVIR fibrosis stage, liver stiffness between 7.6 and 9.5 kPa is considered equivalent to F2 METAVIR fibrosis and liver stiffness > 9.5 kPa is considered to be equivalent to METAVIR fibrosis stage F3F4.